Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 29, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Cap	81	99	66	67	104	144
Market Cap Growth	-6.11%	49.41%	-1.06%	-35.83%	-27.85%	46.50%
Enterprise Value	79.11	93.36	69.4	63.91	103.26	148.03
Last Close Price	5.84	7.15	4.85	4.92	7.68	10.73
PE Ratio	-	21.67	-	-	192.00	536.50
Forward PE	-	119.17	-	-	42.95	77.31
PEG Ratio	-	-	-	-	5.44	5.44
PS Ratio	1.40	1.73	1.31	1.24	2.11	3.51
PB Ratio	18.97	26.12	-34.65	14.37	11.42	19.38
P/TBV Ratio	19.03	27.04	-34.53	14.37	11.96	21.05
P/FCF Ratio	21.29	14.08	-	60.58	25.25	-
P/OCF Ratio	18.49	13.34	-	16.78	15.98	-
EV/Sales Ratio	1.37	1.64	1.38	1.19	2.10	3.61
EV/EBITDA Ratio	-	15.07	-	-	46.22	95.50
EV/EBIT Ratio	-	20.50	-	-	170.11	404.45
EV/FCF Ratio	20.73	13.34	-	58.10	25.11	-
Debt / Equity Ratio	0.77	1.23	-3.20	1.59	0.92	1.18
Debt / EBITDA Ratio	-	0.99	-	-	4.24	6.19
Debt / FCF Ratio	-	0.87	-	7.82	2.30	-
Net Debt / Equity Ratio	-0.52	-0.98	-2.53	-0.33	0.05	0.66
Net Debt / EBITDA Ratio	0.85	-0.59	-0.88	0.51	0.21	3.17
Net Debt / FCF Ratio	-	-0.53	-0.69	-1.38	0.11	-0.99
Asset Turnover	4.07	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.34	0.41	0.56	0.83	1.06	1.04
Current Ratio	0.98	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	-107.03%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	-19.02%	15.82%	-24.23%	-15.28%	1.81%	1.25%
Return on Invested Capital (ROIC)	-44.18%	29.56%	-45.57%	-28.26%	2.86%	2.39%
Return on Capital Employed (ROCE)	-67.57%	69.61%	-85.69%	-34.49%	3.54%	2.95%
Earnings Yield	-	4.62%	-	-	0.52%	0.19%
FCF Yield	4.70%	7.10%	-	1.65%	3.96%	-
Buyback Yield / Dilution	1.39%	-5.31%	-0.04%	4.37%	2.84%	-23.05%
Total Shareholder Return	1.39%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q